Week in Review: Myval TAVR valve's strong performance | Drones deliver AEDs | Did Boston Scientific make the right call?

The LANDMARK trial continues to show positive outcomes for the TAVR valve made in India.

The agreement also will make Boston Scientific the exclusive distributor for the new ICE catheter optimized for left atrial appendage occlusion workflows.

With no treatments available that directly improve INOCA, this breakthrough device offers hope.

SCAI feels this is the best way forward to try lowering mortality rates, but the group is asking cardiologists to help by gathering more data. 

“This study represents a major step forward in how we respond to cardiac arrest in the United States,” explained Monique Starks, MD, principal investigator. “By integrating drone technology into emergency care, we’re working to close the critical gap between cardiac arrest and treatment."

Boston Scientific stopped selling its Acurate TAVR systems after they underperformed in a few key trials and failed to gain FDA approval. Was it the right call?

The cloud-enabled system provides the foundation for future AI-enabled tools, better workflows and analytics.

About 71% of patients in the rewards group opened their blood pressure medication on 80% of days, compared with about 34% in the control group.

According to Hexoskin, the newly cleared technology offers significant value for hospitals and health systems as well as researchers conducting clinical trials.